Combination chemotherapy (MOPP) in the management of advanced Hodgkin's disease. A progress report on 55 patients.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001565:Benzoates / Q000627:therapeutic use*; D001842:Bone and Bones / Q000000981:diagnostic imaging; D004338:Drug Combinations; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy; D006801:Humans; D008111:Liver Function Tests; D008168:Lung / Q000000981:diagnostic imaging; D008297:Male; D008466:Mechlorethamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D011344:Procarbazine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011859:Radiography; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D001565:Benzoates; D004338:Drug Combinations; D011344:Procarbazine; D008466:Mechlorethamine; D014750:Vincristine; D011239:Prednisolone